Medindia

X

RSB Spine, LLC, Announces FDA Clearance for Its InterPlate(TM) C-PS and L-PS Interbody Spacers

Friday, January 29, 2010 General News J E 4
Advertisement


CLEVELAND, Jan. 28 RSB Spine, LLC, today announced that the U.S. Food and Drug Administration has approved the company's 510(k) application to permit the marketing of its InterPlate(TM) C-PS and L-PS Interbody Spacers.

RSB Spine Chief Executive Officer John A. Redmond said: "We are very excited about this new clearance, since it gives our distributors two additional products to offer customers seeking greater options in Zero-ProfileŽ technologies. Our InterPlate portfolio now provides surgeons with the most unique implant combinations on the market."

"Zero-Profile technologies comprise one of the fastest growing segments in the spinal industry," said Mike O'Neill, president of Paradigm BioDevices. "RSB Spine is the only company with a full-line modular interbody platform offering a complete array of material and mechanical loading options that is also code compliant."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.

Zero-ProfileŽ is a registered Service Mark of Paradigm BioDevices, Inc., Rockland, MA.

SOURCE RSB Spine, LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
APTA Calls on Congress to Restore Access to Rehabi...
S
Transplant Program at Baylor Sammons Cancer Center...